Cyber-Physical-Human Systems in Precision Medicine: Advances in Artificial Pancreas for Treatment of Diabetes

  • 0Department of Chemical and Biological Engineering, Illinois Institute of Technology, Chicago, 60616, IL, USA.
Annual Reviews in Control +

|

|

Summary

This summary is machine-generated.

Cyber-physical-human systems (CPHS) leverage digital twins for type 1 diabetes (T1D) management. This AI-powered artificial pancreas automates insulin delivery, improving patient outcomes and reducing disease burden.

Area Of Science

  • Biomedical Engineering
  • Artificial Intelligence in Medicine
  • Computational Physiology

Background

  • Cyber-physical-human systems (CPHS) offer transformative potential in chronic disease management, particularly for diabetes.
  • Advances in artificial intelligence (AI) have accelerated the application of digital twins in healthcare.
  • Digital twins of individuals with type 1 diabetes (T1D) and the pancreas can model complex disease processes.

Purpose Of The Study

  • To develop an AI-enabled automated insulin delivery system using digital twins for T1D management.
  • To create accurate digital twins by integrating mechanistic and data-driven models.
  • To demonstrate the system's capability for real-time, automated treatment decisions in precision medicine.

Main Methods

  • A hybrid modeling framework combining mechanistic physiological and data-driven empirical models was developed.
  • Digital twins of individuals with T1D were created using this framework.
  • The digital twins were integrated into an AI-enabled automated insulin delivery system (artificial pancreas).

Main Results

  • The developed hybrid model accurately represents T1D metabolic, physiologic, and pharmacologic processes.
  • The AI-enabled CPHS successfully automated insulin delivery, mitigating glucose homeostasis disturbances.
  • Simulations and clinical experiments validated the system's performance in real-time precision medicine.

Conclusions

  • Digital twins and AI-driven CPHS represent a significant advancement in T1D treatment.
  • Automated insulin delivery systems improve patient outcomes and reduce the burden of T1D.
  • Future research should focus on online learning, adaptive systems, and cybersecurity for enhanced CPHS.

Related Concept Videos

Diabetes: Management and Pharmacotherapy 01:15

858

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Issues And Trends In Healthcare Delivery System 01:29

6.1K

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Chronic Pancreatitis II: Collaborative Care 01:29

307

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Detailed History: Understanding the patient's symptoms is critical. It includes inquiring about abdominal pain, weight loss, and digestive issues, which are common in chronic pancreatitis.
Physical Examination: This might reveal abdominal tenderness, jaundice, and signs of malnutrition,...